Skip to main content

Table 5 Relationship between tumor absorbed dose and tumor response

From: Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Tumor response

Patients

Tumor dose (Gy)

  

Average

Median

Responders

27

120.3

107.8

Non-responders

13

123.9

76.9

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us